☆ 4.7 Letter

The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma

LEUKEMIA (2010)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 24, Issue 10, Pages 1781-1784

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2010.154

Keywords

-

Categories

Oncology Hematology

Funding

  1. NATIONAL CANCER INSTITUTE [R01CA163217, R01CA096500] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018304] Funding Source: NIH RePORTER
  3. NCI NIH HHS [R01-CA096500, R01 CA096500, R01 CA163217] Funding Source: Medline
  4. NIDCR NIH HHS [R01 DE018304] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.